Login / Signup

Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial.

Mondal AashishNaskar ArindamSheelu Shafiq SiddiqiDeepak BhosleV J MallikarjunaDange AmolSorate SanketGavali OmkarPatel ParthHasnani DhruviPrasad DurgaDalwadi PradeepKumar SureshPathak VaishaliChaudhari MayuraBasu IndraneelShembalkar JayashriFariooqui ArifS K RaghavendraVarade DeepakThakkar RavindraBhanushali ShaishavGaikwad VijayKamran KhanV V MahajaniA D SharmaMayur MayabhateR R PawarA S AiwaleShahavi Vinayaka
Published in: Clinical diabetes and endocrinology (2024)
Clinical Trials Registry of India, CTRI/2021/10/037461.
Keyphrases
  • type diabetes
  • clinical trial
  • cardiovascular disease
  • glycemic control
  • adipose tissue
  • skeletal muscle
  • phase ii
  • phase iii